Association of thymidylate synthase gene with endometrial cancer risk in a chinese population

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 2, 2009, Pages 579-584

  Xu, Wang Hong ^a,b   Long, Ji Rong ^c   Zheng, Wei ^c   Ruan, Zhi Xian ^a   Cai, Qiuyin ^c   Cheng, Jia Rong ^a   Zhao, Gen Ming ^b   Xiang, Yong Bing ^a   Shu, Xiao Ou ^c,d  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYMIDYLATE SYNTHASE;

ARTICLE; CANCER RISK; CHINESE; CONTROLLED STUDY; ENDOMETRIUM CANCER; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POPULATION RESEARCH; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; ENDOMETRIAL NEOPLASMS; FEMALE; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; INCIDENCE; INTRONS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; THYMIDYLATE SYNTHASE;

EID: 60549087716     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0831     Document Type: Article

References (36)

1. Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporaion into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 1997;94:3290-5.
2. Xu WH, Shrubsole MJ, Xiang YB, et al. Dietary folate intake, MTHFR genetic polymorphisms and the risk of endometrial cancer among Chinese women. Cancer Epidemiol Biomarker Prev 2007;16:281-7.
3. Lewis SJ, Harbord RM, Harris R, Smith GD. Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk. J Natl Cancer Inst 2006;98:1607-22.
4. Sharp L, Little J. Human Genome Epidemiology (HuGE) review. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol 2004;159:423-43.
5. Trinh BN, Ong CN, Coetzee GA, Yu MC, Laird PW. Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels. Hum Genet 2002;111:299-302.
6. Chu E, Allegra CJ. The role of thymidylate synthase as an RNA binding protein. BioEssays 1996;18:191-8.
7. Kastanos EK, Zajac-Kaye M, Dennis PA, Allegra CJ. Downregulation of p21/WAF1 expression by thymidylate synthase. Biochem Biophys Res Commun 2001;285:195-200.
8. Ulrich CM, Curtin K, Potter JD, Bigler J, Caan B, Slattery ML. Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 2005;14:2509-16.
9. Chen J, Hunter DJ, Stampfer MJ, et al. Polymorphism in the thymidylate synthase promoter enhancer region modifies the risk and survival of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2003;12:958-62.
10. Matsuo K, Ito H, Wakai K, et al. One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan. Carcinogenesis 2005;26:2164-71.
11. Xu X, Gammon MD, Zhang H, et al. Polymorphisms of one-carbon-metabolizing genes and risk of breast cancer in a population-based study. Carcinogenesis 2007;28:1504-9.
12. Zhai X, Gao J, Hu Z, et al. Polymorphisms in thymidylate synthase gene and susceptibility to breast cancer in a Chinese population: a case-control analysis. BMC Cancer 2006;6:138.
13. Horie N, Aiba H, Oguro K, Hojo H, Takeishi K. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5'-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct Funct 1995;20:191-7.
14. Ulrich CM, Bigler J, Velicer CM, Greene EA, Farin FM, Potter JD.Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene. Cancer Epidemiol Biomarkers Prev 2000;9:1381-5.
15. Nief N, Le Morvan V, Robert J. Involvement of gene polymorphisms of thymidylate synthase in gene expression, protein activity and anticancer drug cytotoxicity using the NCI-60 panel. Eur J Cancer 2007;43:955-62.
16. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Gene 2005;37:1217-23.
17. Hardenbol P, Yu F, Belmont J, et al. Highly multiplexed molecular inversion probe genotyping: over 10,000 targeted SNPs genotyped in a single tube assay. Genome Res 2005;15:269-75.
18. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
19. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-9.
20. Lin DY, Zeng D, Millikan R. Maximum likelihood estimation of haplotype effects and haplotype-environment interactions in association studies. Genet Epidemiol 2005;29:299-312.
21. James SJ, Basnakian AG, Miller BJ. In vitro folate deficiency induces deoxynucleotide pool imbalance, apoptosis and mutagenesis in Chinese hamster ovary cells. Cancer Res 1994;54:5075-80.
22. Bebenek K, Roberts JD, Kunkel TA. The effects of dNTP pool imbalances on frameshift fidelity during DNA replication. J Biol Chem 1992;267:3589-96.
23. Snyder RD. Effects of nucleotide pool imbalances on the excision repair of ultraviolet-induced damage in the DNA of human diploid fibroblasts. Basic Life Sci 1985;31:163-73.
24. Phear G, Meuth M. The genetic consequences of DNA precursor pool imbalance: sequence analysis of mutations induced by excess thymidine at the hamster aprt locus. Mutat Res 1989;214:201-6.
25. Zhang J, Cui Y, Kuang G, et al. Association of the thymidylate synthase polymorphisms with esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma. Carcinogenesis 2004;25:2479-85.
26. Graziano F, Kawakami K, Watanabe G, et al. Association of thymidylate synthase polymorphisms with gastric cancer susceptibility. Int J Cancer 2004;112:1010-4.
27. Zhang Z, Xu Y, Zhou J, et al. Polymorphisms of thymidylate synthase in the 5'- and 3'-untranslated regions associated with risk of gastric cancer in South China: a case-control analysis. Carcinogenesis 2005;26:1764-9.
28. Zhang Z, Shi Q, Sturgis EM, Spitz MR, Hong WK, Wei Q. Thymidylate synthase 5'- and 3'-untranslated region polymorphisms associated with risk and progression of squamous cell carcinoma of the head and neck. Clin Cancer Res 2004;10:7903-10.
29. Shi Q, Zhang Z, Neumann AS, Li G, Spitz MR, Wei Q. Case-control analysis of thymidylate synthase polymorphisms and risk of lung cancer. Carcinogenesis 2005;26:649-56.
30. Yuan JM, Lu SC, Van Den Berg D, et al. Genetic polymorphisms in the methylenetetrahydrofolate reductase and thymidylate synthase genes and risk of hepatocellular carcinoma. Hepatology 2007;46:749-58.
31. Kim SR, Ozawa S, Saito Y, et al. Fourteen novel genetic variations and haplotype structures of the TYMS gene encoding human thymidylate synthase (TS). Drug Metab Pharmacokinet 2006;21:509-16.
32. Dolnick BJ. Cloning and characterization of a naturally occurring antisense RNA to human thymidylate synthase mRNA. Nucleic Acids Res 1993;21:1747-52.
33. Dolnick BJ, Black AR, Winkler PM, Schindler K, Hsueh CT. rTS gene expression is associated with altered cell sensitivity to thymidylate synthase inhibitors. Adv Enzyme Regul 1996;36:165-80.
34. Chu J, Dolnick BJ. Natural antisense (rTSα) RNA induces site-specific cleavage of thymidylate synthase mRNA. Biochim Biophys Acta 2002;1587:183-93.
35. Dolnick BJ, Angelino NJ, Dolnick R, Sufrin JR. A novel function for the rTS gene. Cancer Biol Ther 2003;2:364-9.
36. Xie W, Duan R, Chen I, Samudio I, Safe S. Transcriptional activation of thymidylate synthase by 17β-estradiol in MCF-7 human breast cancer cells. Endocrinology 2000;141:2439-49.